ED
56
-3
USB
55
2
MMM
56
7
CMG
44
-3
CRM
35
3
CSCO
50
2
CHRW
50
-3
TROW
31
-3
PH
63
3
CA
10
-6
MLM
48
3
EBAY
42
2
WFC
68
7
CAT
40
-2
MCK
74
-4
SO
62
-4
LUV
59
-2
DLTR
36
-2
TGT
40
-3
XOM
56
2
ED
56
-3
USB
55
2
MMM
56
7
CMG
44
-3
CRM
35
3
CSCO
50
2
CHRW
50
-3
TROW
31
-3
PH
63
3
CA
10
-6
MLM
48
3
EBAY
42
2
WFC
68
7
CAT
40
-2
MCK
74
-4
SO
62
-4
LUV
59
-2
DLTR
36
-2
TGT
40
-3
XOM
56
2
Financhill
Back

United Community Banks Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
59

UCB
United Community Banks

Last Price:
$27.89
Seasonality Move:
7.07%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.39
Seasonality Move:
6.73%
Buy
59
United Community Banks (UCB) is a Buy

Is United Community Banks a Buy, Sell or Hold?

  • The current United Community Banks [UCB] share price is $28.43. The Score for UCB is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • UCB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UCB Stock Price Chart

What is United Community Banks's stock price today?

  • The United Community Banks share price today is $28.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UCB is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

UCB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.05 Sell
Relative Strength Index (14 RSI): 27.54 Sell
Chaikin Money Flow: 297077 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.35 - 33.95) Sell
Bollinger Bands (100): (29.92 - 33.78) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

UCB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.12 Sell
20-day SMA: 31.76 Sell
50-day SMA: 32.19 Sell
200-day SMA: 29.76 Sell
8-day EMA: 29.78 Sell
20-day EMA: 31.11 Sell
50-day EMA: 31.85 Sell
200-day EMA: 30.34 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

United Community Banks Earnings Growth & UCB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.21 per share, and an increase next year of $0.25 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

United Community Banks Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):